HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Formula Claims Draft Guidance: Health And Wellness Industry News Roundup

This article was originally published in The Rose Sheet

Executive Summary

FTC considers Vemma settlement; UK firm's green tea claim fails; Axxess has new CEO; NeutraSci reaches Austria, Germany; and more news in brief.

You may also be interested in...

UK Turmeric Supplement Ads Outed For Using Claims 'On Hold' At EFSA

In separate rulings, ASA upholds complains that Healthspan and Cambridge Nutraceuticals made unapproved health claims for turmeric, as the firms did not provide sufficient supporting evidence and cannot rely on similar “on hold” claims on the ingredient under review by EFSA.

More Time For Formula Claim Guidance Comment: Health And Wellness Industry News Roundup

Mannatech founder Robbins leaves board; Nutra recalls GNC Women's supplement; historic UK center licenses Agragen omega-3 technology; and AngioSoma gains nutraceutical formulation patents

FTC Pyramid Scheme Investigation Brings Energy Drink Direct Seller To Standstill

FTC shuts down Vemma Nutrition on allegations of targeting college students and other young consumers in a pyramid scheme. The agency’s complaint in federal court follows consumer advocate Truth In Advertising’s two-year investigation of Vemma.


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts